RecruitingPhase 4NCT06072482
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Studying Anti-neutrophil cytoplasmic antibody-associated vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amgen
- Principal Investigator
- MDAmgen
- Intervention
- Avacopan(drug)
- Enrollment
- 300 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2024 – 2036
Study locations (30)
- Orthopedic Physicians Alaska, Anchorage, Alaska, United States
- Scottsdale Healthcare at Shea - HonorHealth, Scottsdale, Arizona, United States
- Southwest Kidney Institute, Surprise, Arizona, United States
- Medvin Clinical Research, Covina, California, United States
- Palo Alto Medical Foundation Fremont, Fremont, California, United States
- The Nephrology Group, Fresno, California, United States
- Providence Medical Foundation, Fullerton, California, United States
- Medvin Clinical Research, Menifee, California, United States
- University of California San Francisco- Zuckerburg San Francisco General, San Francisco, California, United States
- Harbor University of California at Los Angeles Medical Center, Torrance, California, United States
- University of Colorado, Aurora, Colorado, United States
- Florida Kidney Physicians, Boca Raton, Florida, United States
- Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida, United States
- Mayo Clinic, Jacksonville, Florida, United States
- ClinTrial Research Oakwater, Llc, Orlando, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06072482 on ClinicalTrials.govOther trials for Anti-neutrophil cytoplasmic antibody-associated vasculitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07556484Pharmacokinetics Of Emulsified Avacopan Applied By NG TubeMayo Clinic
- RECRUITINGEARLY PHASE1NCT07507201Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune DiseaseThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNCT07258524PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated VasculitisUniversity of Edinburgh
- RECRUITINGPHASE1NCT07315087CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune DiseasesInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT07160608Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisAlexion Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT07168161BDB-001 Phase III Trial in ANCA-Associated VasculitisStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE3NCT06983821Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)Ottawa Hospital Research Institute
- RECRUITINGNCT07151521(68)Ga-FAPI PET/CT in Patients With ANCA-associated VasculitisRuijin Hospital
See all trials for Anti-neutrophil cytoplasmic antibody-associated vasculitis →